Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Find effective ways to cut costs without giving up your favorite activities. Smart budgeting can help you save while enjoying life.
24,544 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Pope Leo XIV issues Magnifica Humanitas, framing AI as a modern social contract test that echoes the Industrial Revol...
A CEO’s large stock sale can spark questions about a company’s trajectory. This guide breaks down what genomics sells...
Solayer unveils Margin Trade mainnet, a Solana-native onchain perpetuals platform that lets traders manage crypto, co...
A practical guide to building a focused AI stock portfolio with $5,000. Learn which five names to consider, how to al...
A $10,000 investment in Asia’s biggest stocks grew to $15,267 by June 3, 2026, outpacing most U.S. large caps and hig...
Last month, poet technologies skyrocketed 72.6%, delivering a dramatic rally in a volatile sector. This article expla...
IBM is shifting to a software-led model with accelerating cash flow and a higher dividend, signaling a durable, AI-ti...
Investors face a decisive choice: lean into specialized aerospace parts with HEICO or embrace Textron’s diversified i...
AI shopping agents are moving toward handling purchases, but experts say readiness gaps, fraud concerns, and retailer...
Trading in spot hype ETFs nears the $900 million mark in a single session, signaling emerging institutional interest....
A New York-based AI startup led by a 21-year-old cofounder pitches clients with a provocative call to skepticism. The...